Volitionrx (VNRX) EBT Margin Growth (3y) (2022 - 2025)
Volitionrx (VNRX) EBT Margin Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 1,391.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -176.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 329.00 |
| 10 | Volitionrx | 50.46 Mn | 48.00 Mn | -1.01 Mn | -698,910.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -698,910.00 |
| Sep 30, 2025 | -21,769.00 |
| Jun 30, 2025 | -19,966.00 |
| Mar 31, 2025 | -231,456.00 |
| Dec 31, 2024 | -192,891.00 |
| Sep 30, 2024 | -18,843.00 |
| Jun 30, 2024 | -17,297.00 |
| Mar 31, 2024 | -491,979.00 |
| Dec 31, 2023 | -391,321.00 |
| Sep 30, 2023 | -663,744.00 |
| Jun 30, 2023 | -451,324.00 |
| Mar 31, 2023 | 190.18 Mn |
| Dec 31, 2022 | 2.22 Mn |